President Trump unveiled a deal with drugmaker Regeneron on Thursday for the company to voluntarily cut prices, the final manufacturer to commit to the White House’s “most favored nation” plan to lower U.S. costs in line with other developed nations. Under the agreement, Regeneron said it will reduce prices for its current and future medications sold to…
